To study possible antifibrotic effects in vivo, we used two different models of progressive fibrosis where activin subunits were expressed differently (in the asbestos model only activin-A was upregulated, whereas in the silica model both activin-A and -B were upregulated). The gene discussed is INHBE; the disease is fibrosis.